The Build Back Better bill gives Medicare the power to buy drugs cheaply. No wonder Big Pharma is trying to smear it.
Inside the life of a rural hospital.
Why Biogen’s medication, aducanumab, should get studied through an important part of the Affordable Care Act, the Patient Centers Outcomes Research Institute.
Public option proponents face huge political hurdles; there is another way to achieve many of the same goals.
Public health agencies need to make menthol smokers, Black and white, aware of safer alternatives. Anything less isn’t social justice.
The president abandons the long-held view that innovation requires high prices.
Poorly paid direct care workers with multiple jobs who can’t afford sick leave spread the pandemic to the most vulnerable. Here’s how we can do better.
Part of me gets the need to balance risk. Part of me wants to scream.
The shots are saving lives, but we don’t know their long-term effects thanks to an agency that often answers to industry instead of the public.
Every metric puts D.C. one or two notches up from dead last. Even Mississippi does it better. Why isn’t this a bigger story?